Prevention of Viral Hepatitis and HIV Infection among People Who Inject Drugs: A Systematic Review and Meta-Analysis
This study aimed to explore the current evidence on preventing blood-borne virus infections among people who inject drugs (PWID). We conducted a comprehensive search across three databases (PubMed, Embase, Cochrane Library) for relevant articles published in English between 2014 and 2023. We followe...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/16/1/142 |
_version_ | 1797342398905319424 |
---|---|
author | Yen-Ju Chen Yu-Chen Lin Meng-Tien Wu Jenn-Yuan Kuo Chun-Hsiang Wang |
author_facet | Yen-Ju Chen Yu-Chen Lin Meng-Tien Wu Jenn-Yuan Kuo Chun-Hsiang Wang |
author_sort | Yen-Ju Chen |
collection | DOAJ |
description | This study aimed to explore the current evidence on preventing blood-borne virus infections among people who inject drugs (PWID). We conducted a comprehensive search across three databases (PubMed, Embase, Cochrane Library) for relevant articles published in English between 2014 and 2023. We followed the Preferred Reporting Items for Systematic Reviews and Meta Analysis (PRISMA) guidelines, assessed the quality of the paper using the revised Cochrane Risk of Bias Tool (ROB 2), and conducted a meta-analysis using RevMan 5.3. Completing the harm reduction program (HRP) participation and receiving all three vaccine doses resulted in a 28% reduction in the risk of HBV infection (OR: 0.72, 95% CI: 0.37–1.42). Various interventions increased the willingness of PWIDs to undergo HCV treatment (OR: 5.91, 95% CI: 2.46–14.24) and promoted treatment adherence (OR: 15.04, 95% CI: 2.80–80.61). Taking PrEP, participating in HRP, and modifying risky behaviors were associated with a 33% reduction in the risk of HIV infection (OR: 0.67, 95% CI: 0.61–0.74). Conducting referrals, providing counseling, and implementing antiretroviral therapy resulted in a 44% reduction in the risk of viral transmission (OR: 0.56, 95% CI: 0.47–0.66). Co-infection may potentially compromise effectiveness, so it is important to consider drug resistance. |
first_indexed | 2024-03-08T10:32:43Z |
format | Article |
id | doaj.art-a907785e3f314ee091f4fc1f08320f6f |
institution | Directory Open Access Journal |
issn | 1999-4915 |
language | English |
last_indexed | 2024-03-08T10:32:43Z |
publishDate | 2024-01-01 |
publisher | MDPI AG |
record_format | Article |
series | Viruses |
spelling | doaj.art-a907785e3f314ee091f4fc1f08320f6f2024-01-26T18:48:34ZengMDPI AGViruses1999-49152024-01-0116114210.3390/v16010142Prevention of Viral Hepatitis and HIV Infection among People Who Inject Drugs: A Systematic Review and Meta-AnalysisYen-Ju Chen0Yu-Chen Lin1Meng-Tien Wu2Jenn-Yuan Kuo3Chun-Hsiang Wang4Research Assistant Center, Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation), Tainan 701033, TaiwanResearch Assistant Center, Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation), Tainan 701033, TaiwanResearch Assistant Center, Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation), Tainan 701033, TaiwanDepartment of Hepatogastroenterology, Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation), Tainan 701033, TaiwanDepartment of Hepatogastroenterology, Tainan Municipal Hospital (Managed by Show Chwan Medical Care Corporation), Tainan 701033, TaiwanThis study aimed to explore the current evidence on preventing blood-borne virus infections among people who inject drugs (PWID). We conducted a comprehensive search across three databases (PubMed, Embase, Cochrane Library) for relevant articles published in English between 2014 and 2023. We followed the Preferred Reporting Items for Systematic Reviews and Meta Analysis (PRISMA) guidelines, assessed the quality of the paper using the revised Cochrane Risk of Bias Tool (ROB 2), and conducted a meta-analysis using RevMan 5.3. Completing the harm reduction program (HRP) participation and receiving all three vaccine doses resulted in a 28% reduction in the risk of HBV infection (OR: 0.72, 95% CI: 0.37–1.42). Various interventions increased the willingness of PWIDs to undergo HCV treatment (OR: 5.91, 95% CI: 2.46–14.24) and promoted treatment adherence (OR: 15.04, 95% CI: 2.80–80.61). Taking PrEP, participating in HRP, and modifying risky behaviors were associated with a 33% reduction in the risk of HIV infection (OR: 0.67, 95% CI: 0.61–0.74). Conducting referrals, providing counseling, and implementing antiretroviral therapy resulted in a 44% reduction in the risk of viral transmission (OR: 0.56, 95% CI: 0.47–0.66). Co-infection may potentially compromise effectiveness, so it is important to consider drug resistance.https://www.mdpi.com/1999-4915/16/1/142prevention strategiesblood-borne virus infectionpeople who inject drugs (PWID)systematic reviewmeta-analysis |
spellingShingle | Yen-Ju Chen Yu-Chen Lin Meng-Tien Wu Jenn-Yuan Kuo Chun-Hsiang Wang Prevention of Viral Hepatitis and HIV Infection among People Who Inject Drugs: A Systematic Review and Meta-Analysis Viruses prevention strategies blood-borne virus infection people who inject drugs (PWID) systematic review meta-analysis |
title | Prevention of Viral Hepatitis and HIV Infection among People Who Inject Drugs: A Systematic Review and Meta-Analysis |
title_full | Prevention of Viral Hepatitis and HIV Infection among People Who Inject Drugs: A Systematic Review and Meta-Analysis |
title_fullStr | Prevention of Viral Hepatitis and HIV Infection among People Who Inject Drugs: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Prevention of Viral Hepatitis and HIV Infection among People Who Inject Drugs: A Systematic Review and Meta-Analysis |
title_short | Prevention of Viral Hepatitis and HIV Infection among People Who Inject Drugs: A Systematic Review and Meta-Analysis |
title_sort | prevention of viral hepatitis and hiv infection among people who inject drugs a systematic review and meta analysis |
topic | prevention strategies blood-borne virus infection people who inject drugs (PWID) systematic review meta-analysis |
url | https://www.mdpi.com/1999-4915/16/1/142 |
work_keys_str_mv | AT yenjuchen preventionofviralhepatitisandhivinfectionamongpeoplewhoinjectdrugsasystematicreviewandmetaanalysis AT yuchenlin preventionofviralhepatitisandhivinfectionamongpeoplewhoinjectdrugsasystematicreviewandmetaanalysis AT mengtienwu preventionofviralhepatitisandhivinfectionamongpeoplewhoinjectdrugsasystematicreviewandmetaanalysis AT jennyuankuo preventionofviralhepatitisandhivinfectionamongpeoplewhoinjectdrugsasystematicreviewandmetaanalysis AT chunhsiangwang preventionofviralhepatitisandhivinfectionamongpeoplewhoinjectdrugsasystematicreviewandmetaanalysis |